NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 3D HNCACB | 0.5 mM [U-13C; U-15N; U-2H] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide | 90% H2O/10% D2O | 0.2 | 7.5 | ambient | 310 | |
2 | 3D HNCO | 0.5 mM [U-13C; U-15N; U-2H] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide | 90% H2O/10% D2O | 0.2 | 7.5 | ambient | 310 | |
3 | 3D HCACO | 0.5 mM [U-13C; U-15N; U-2H] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide | 90% H2O/10% D2O | 0.2 | 7.5 | ambient | 310 | |
4 | 3D HN(COCA)CB | 0.5 mM [U-13C; U-15N; U-2H] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide | 90% H2O/10% D2O | 0.2 | 7.5 | ambient | 310 | |
5 | 3D HNCO type RDC | 0.5 mM [U-13C; U-15N; U-2H] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide, 14 mg/mL pf1 phage | 90% H2O/10% D2O | 0.2 | 7.5 | ambient | 310 | |
6 | 2D 1H-15N HSQC IPAP | 0.5 mM [U-13C; U-15N; U-2H] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide, 14 mg/mL pf1 phage | 90% H2O/10% D2O | 0.2 | 7.5 | ambient | 310 | |
7 | 3D HCCH-TOCSY | 0.5 mM [U-13C; U-2H], I/L/V methyl [1H,13C] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide | 100% D2O | 0.2 | 7.5 | ambient | 310 | |
8 | 2D 1H-13C HSQC | 0.5 mM [U-10% 13C] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide | 100% D2O | 0.2 | 7.5 | ambient | 310 | |
9 | 3D HNCO type RDC | 0.5 mM [U-13C; U-15N; U-2H] CIB1, 5 mM [U-2H] DTT, 2 mM CALCIUM ION, 100 mM sodium chloride, 50 mM HEPES, 0.6 mM aIIb peptide, 5 % C12E5/glycerol (0.96/1) | 90% H2O/10% D2O | 0.2 | 7.5 | ambient | 310 | |